This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 May;16(5):e196-7.

doi: 10.1016/S1470-2045(15)70063-X.

Radiotherapy for elderly patients with low-risk breast cancer

Orit Kaidar-Person¹, Philip Poortmans², Abraham Kuten³, David A L Morgan⁴

Affiliations

Affiliations

¹ Division of Oncology, Rambam Health Care Campus, Haifa 31096, Israel. Electronic address: o_person@rambam.health.gov.il.
² Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
³ Oncology Service, Italian Hospital of Haifa, Haifa, Israel.
⁴ Breast Services, Sherwood Forest Hospitals NHS Foundation Trust, Nottinghamshire, England.

PMID: 25943058
DOI: 10.1016/S1470-2045(15)70063-X

Comment

Radiotherapy for elderly patients with low-risk breast cancer

Orit Kaidar-Person et al. Lancet Oncol. 2015 May.

. 2015 May;16(5):e196-7.

doi: 10.1016/S1470-2045(15)70063-X.

Authors

Orit Kaidar-Person¹, Philip Poortmans², Abraham Kuten³, David A L Morgan⁴

Affiliations

¹ Division of Oncology, Rambam Health Care Campus, Haifa 31096, Israel. Electronic address: o_person@rambam.health.gov.il.
² Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
³ Oncology Service, Italian Hospital of Haifa, Haifa, Israel.
⁴ Breast Services, Sherwood Forest Hospitals NHS Foundation Trust, Nottinghamshire, England.

PMID: 25943058
DOI: 10.1016/S1470-2045(15)70063-X

No abstract available

PubMed Disclaimer

Comment on

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.
Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM; PRIME II investigators. Kunkler IH, et al. Lancet Oncol. 2015 Mar;16(3):266-73. doi: 10.1016/S1470-2045(14)71221-5. Epub 2015 Jan 28. Lancet Oncol. 2015. PMID: 25637340 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information